Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Results of phase II Multikine cancer study promising

Feb. 22, 2000

Aventis and MediGene to codevelop melanoma vaccine

Feb. 21, 2000

Campath BLA accepted for filing

Feb. 17, 2000

NCI extends two CRADAs with Therion Biologics for cancer vaccines

Feb. 17, 2000

Stimulation of HAMA with radiolabeled MAb appears to confer survival advantage in ovarian cancer

Feb. 11, 2000

Potential new use for imiquimod explored in small clinical study

Feb. 10, 2000

Update on Immunex's rhuCD40L, including latest preclinical data

Feb. 10, 2000

News from 31st SGO: excellent results obtained with OvaRex in selected heavily pretreated patients

Feb. 9, 2000

Two additional U.S. patents allowed for Maxamine technology

Feb. 3, 2000

Biomira reports survival data for therapeutic cancer vaccine

Jan. 31, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...